Managing Gout Attacks in Patients on Allopurinol: Options and Considerations

When a patient on allopurinol develops a gout attack, it is important to manage the acute inflammation while continuing the prophylactic treatment. Here are some options and considerations:

– Continue allopurinol and start oral colchicine: Colchicine can be used for acute treatment, but allopurinol should not be stopped.
– Increase allopurinol dose: The dose may need to be increased up to 600 mg for better prophylaxis, but not during an acute attack.
– Stop allopurinol and recommence two weeks after acute inflammation settled: Allopurinol should not be stopped during an attack. It should be continued at the same dose.
– Stop allopurinol and start non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs can control acute pain, but not appropriate for patients with a history of peptic ulcer.
– Stop allopurinol and recommence at a higher dose after acute inflammation has settled: Allopurinol should not be stopped during an attack. The dose can be reviewed and increased after the attack has settled down.

In summary, managing gout attacks in patients on allopurinol requires a careful balance between acute treatment and prophylaxis. Each option should be considered based on the patient’s individual circumstances and medical history.

If a patient with BPH has a significantly enlarged prostate, 5 alpha-reductase inhibitors should be considered as a second-line treatment option. Finasteride is an example of a 5 alpha-reductase inhibitor and is used when alpha-1-antagonists fail to manage symptoms. Desmopressin is a later stage drug used for BPH with nocturnal polyuria after other treatments have failed. Tamsulosin is an alpha-1-antagonist and is the first-line option for BPH. Terazosin is another alpha-blocker and could also be used as a first-line option.

Benign prostatic hyperplasia (BPH) is a common condition that affects older men, with around 50% of 50-year-old men showing evidence of BPH and 30% experiencing symptoms. The risk of BPH increases with age, with around 80% of 80-year-old men having evidence of the condition. BPH typically presents with lower urinary tract symptoms (LUTS), which can be categorised into voiding symptoms (obstructive) and storage symptoms (irritative). Complications of BPH can include urinary tract infections, retention, and obstructive uropathy.

Assessment of BPH may involve dipstick urine tests, U&Es, and PSA tests. A urinary frequency-volume chart and the International Prostate Symptom Score (IPSS) can also be used to assess the severity of LUTS and their impact on quality of life. Management options for BPH include watchful waiting, alpha-1 antagonists, 5 alpha-reductase inhibitors, combination therapy, and surgery. Alpha-1 antagonists are considered first-line treatment for moderate-to-severe voiding symptoms, while 5 alpha-reductase inhibitors may be indicated for patients with significantly enlarged prostates and a high risk of progression. Combination therapy and antimuscarinic drugs may also be used in certain cases. Surgery, such as transurethral resection of the prostate (TURP), may be necessary in severe cases.

The presence of Down’s syndrome can be indicated by an increase in beta-HCG, a decrease in PAPP-A, and the observation of a thickened nuchal translucency during ultrasound. The other options involving beta-HCG and PAPP-A are incorrect. The combined screening test is usually conducted between the 10th and 14th week of pregnancy and involves an ultrasound to measure nuchal thickness, as well as blood tests to assess beta-HCG and PAPP-A levels. A positive result suggests a higher risk of Down’s syndrome, Patau’s syndrome, and Edward’s syndrome. In such cases, amniocentesis, chorionic villus sampling, or non-invasive prenatal testing may be offered to confirm the diagnosis. The options involving inhibin A are not part of the combined screening test. If a woman presents later in pregnancy, the quadruple test may be used instead, which involves four blood markers to determine the risk of Down’s syndrome. These markers include inhibin A, alpha-fetoprotein, unconjugated oestriol, and beta-HCG. A positive result for Down’s syndrome would typically show raised beta-HCG and inhibin A, and low unconjugated oestriol and alpha-fetoprotein.

NICE updated guidelines on antenatal care in 2021, recommending the combined test for screening for Down’s syndrome between 11-13+6 weeks. The test includes nuchal translucency measurement, serum B-HCG, and pregnancy-associated plasma protein A (PAPP-A). The quadruple test is offered between 15-20 weeks for women who book later in pregnancy. Results are interpreted as either a ‘lower chance’ or ‘higher chance’ of chromosomal abnormalities. If a woman receives a ‘higher chance’ result, she may be offered a non-invasive prenatal screening test (NIPT) or a diagnostic test. NIPT analyzes cell-free fetal DNA in the mother’s blood and has high sensitivity and specificity for detecting chromosomal abnormalities. Private companies offer NIPT screening from 10 weeks gestation.

Understanding Pituitary Lesions and their Symptoms

The pituitary gland is a small gland located at the base of the brain that produces and releases hormones that regulate various bodily functions. Lesions in different parts of the pituitary gland can cause a range of symptoms.

Anterior Pituitary: Ischaemic necrosis of the anterior pituitary can occur following post-partum haemorrhage, leading to varying symptoms of hypopituitarism. The most common initial symptom is low or absent prolactin, resulting in failure to commence lactation. Other symptoms may include amenorrhoea, hypothyroidism, glucocorticoid deficiency, and loss of genital and axillary hair. Treatment requires hormone supplementation and involvement of an endocrinologist.

Hypothalamus: Lesions in the hypothalamus can cause hyperthermia/hypothermia, aggressive behaviour, somnolence, and Horner syndrome.

Cerebral Cortex: Lesions in the cerebral cortex are associated with stroke or multiple sclerosis and affect different functions such as speech, movement, hearing, and sight.

Posterior Pituitary: Lesions in the posterior pituitary are associated with central diabetes insipidus.

Pituitary Stalk: Lesions in the pituitary stalk are associated with diabetes insipidus, hypopituitarism, and hyperprolactinaemia. The patient presents with galactorrhoea, irregular menstrual periods, and other symptoms related to hyperprolactinaemia due to the lifting of dopamine neurotransmitter release inhibition.

Identifying the Cause of Weakness in Elbow Flexion and Supination: Biceps Brachii Muscle Injury

The biceps brachii muscle plays a crucial role in elbow flexion and supination of the forearm. When a patient presents with weakness in both of these movements, along without loss of skin sensation, a biceps brachii injury is the most likely cause. In contrast, damage to the brachialis muscle would only affect elbow flexion, while damage to the pronator teres muscle would only affect forearm pronation. The musculocutaneous nerve, which innervates the biceps brachii and brachialis muscles, as well as the coracobrachialis muscle, would also result in sensory loss if damaged. The supinator muscle, on the other hand, only plays a role in supination and would not cause weakness in elbow flexion. Therefore, identifying the specific muscle involved is crucial in determining the cause of weakness in elbow flexion and supination.

Diagnostic Markers for Polymyalgia Rheumatica and Temporal arthritis

Polymyalgia rheumatica and temporal arthritis are inflammatory conditions that can cause significant morbidity if left untreated. Here are some diagnostic markers that can help support or rule out these conditions:

Plasma viscosity: A raised plasma viscosity can support a diagnosis of polymyalgia rheumatica with temporal arthritis, but it is a nonspecific inflammatory marker.

Creatine kinase: A raised creatine kinase is not supportive of a diagnosis of polymyalgia rheumatica or temporal arthritis.

Monospot test: A positive monospot test is supportive of a diagnosis of Epstein–Barr virus (EBV), but not polymyalgia rheumatica or temporal arthritis.

Whole cell count (WCC): A raised WCC is not supportive of a diagnosis of polymyalgia rheumatica or temporal arthritis.

Bence Jones proteins: Presence of Bence Jones protein is supportive of a diagnosis of multiple myeloma, but not polymyalgia rheumatica or temporal arthritis.

If temporal arthritis is suspected, immediate treatment with prednisolone is crucial to prevent permanent loss of vision. A temporal artery biopsy can confirm the diagnosis.

Differential Diagnosis of a Patient with Gait Dyspraxia, Confusion, and Urinary Incontinence

The presenting symptoms of gait dyspraxia, fluctuating confusion, and urinary incontinence can be indicative of various conditions in the elderly population. However, the classical triad of normal pressure hydrocephalus (NPH) is a possible diagnosis that requires clinical expertise and imaging studies, such as a CT or MRI scan, to confirm the presence of hydrocephalus with relatively well-preserved sulci. Lumbar puncture studies can also aid in the diagnosis of NPH, and the insertion of a ventriculo-peritoneal shunt may be curative.

Idiopathic intracranial hypertension is a disease that primarily affects young women and can lead to devastating neurological effects, including blindness. Wernicke’s encephalopathy, caused by thiamine deficiency, is characterized by a progressive confusional state, ataxia, and ophthalmoplegia. Herpes encephalitis is a rapidly fatal cause of encephalitis that presents with severe headache, confusion, or reduced level of consciousness. However, the absence of a severe headache and the need for serial lumbar punctures to confirm the diagnosis make NPH a more likely diagnosis in this case.

A colloid cyst of the third ventricle is a benign tumor that is usually discovered incidentally on a brain scan. While it may cause fluctuating confusion and symptoms of raised intracranial pressure, including headaches, it would not require serial lumbar punctures to confirm the diagnosis. In rare cases, it may also cause weakness of the lower limbs and episodes of collapse.

To prevent the recurrence of an indirect inguinal hernia, pressure should be applied over the deep inguinal ring after reducing the hernia. This is because the hernia protrudes through the inguinal canal and covering the deep inguinal ring prevents it from reappearing during activities that increase intra-abdominal pressure, such as coughing. Noting bilateral herniae is not relevant to confirming or refuting the diagnosis, and there is no such thing as a femoral ring. If the lump reappears during coughing while covering the deep inguinal ring, it may indicate a direct hernia instead. It is important to distinguish between indirect and direct herniae during surgical repair, as they occur in different locations relative to the inferior epigastric blood vessels due to a hole in the internal oblique and transversus muscles.

Abdominal wall hernias occur when an organ or the fascia of an organ protrudes through the wall of the cavity that normally contains it. Risk factors for developing these hernias include obesity, ascites, increasing age, and surgical wounds. Symptoms of abdominal wall hernias include a palpable lump, cough impulse, pain, obstruction (more common in femoral hernias), and strangulation (which can compromise the bowel blood supply and lead to infarction). There are several types of abdominal wall hernias, including inguinal hernias (which account for 75% of cases and are more common in men), femoral hernias (more common in women and have a high risk of obstruction and strangulation), umbilical hernias (symmetrical bulge under the umbilicus), paraumbilical hernias (asymmetrical bulge), epigastric hernias (lump in the midline between umbilicus and xiphisternum), incisional hernias (which may occur after abdominal surgery), Spigelian hernias (rare and seen in older patients), obturator hernias (more common in females and can cause bowel obstruction), and Richter hernias (a rare type of hernia that can present with strangulation without symptoms of obstruction). In children, congenital inguinal hernias and infantile umbilical hernias are the most common types, with surgical repair recommended for the former and most resolving on their own for the latter.

Having had one previous caesarean section, the majority of women can have a successful vaginal delivery. A fundal placenta, which is attached at the top of the uterus away from the cervical os, is a favorable location for a placenta and does not require a caesarean section. However, a previous caesarean section does increase the risk of placenta praevia, where the placenta covers the cervical os, which may require a caesarean section. Inducing vaginal delivery at 36-37 weeks is not recommended in this case, as it is not a suitable option. While maternal age of 37 may pose some risks during pregnancy and birth, it is not a determining factor for a caesarean section unless there are other concerns.

Caesarean Section: Types, Indications, and Risks

Caesarean section, also known as C-section, is a surgical procedure that involves delivering a baby through an incision in the mother’s abdomen and uterus. In recent years, the rate of C-section has increased significantly due to an increased fear of litigation. There are two main types of C-section: lower segment C-section, which comprises 99% of cases, and classic C-section, which involves a longitudinal incision in the upper segment of the uterus.

C-section may be indicated for various reasons, including absolute cephalopelvic disproportion, placenta praevia grades 3/4, pre-eclampsia, post-maturity, IUGR, fetal distress in labor/prolapsed cord, failure of labor to progress, malpresentations, placental abruption, vaginal infection, and cervical cancer. The urgency of C-section may be categorized into four categories, with Category 1 being the most urgent and Category 4 being elective.

It is important for clinicians to inform women of the serious and frequent risks associated with C-section, including emergency hysterectomy, need for further surgery, admission to intensive care unit, thromboembolic disease, bladder injury, ureteric injury, and death. C-section may also increase the risk of uterine rupture, antepartum stillbirth, placenta praevia, and placenta accreta in subsequent pregnancies. Other complications may include persistent wound and abdominal discomfort, increased risk of repeat C-section, readmission to hospital, haemorrhage, infection, and fetal lacerations.

Vaginal birth after C-section (VBAC) may be an appropriate method of delivery for pregnant women with a single previous C-section delivery, except for those with previous uterine rupture or classical C-section scar. The success rate of VBAC is around 70-75%.

Cervical ectropions are frequently observed in young women who are on COCP and experience post-coital bleeding. Although cervical cancer should be taken into account, the probability of it being the cause is reduced if the woman has had a recent normal smear. In such cases, ectropion is more probable.

Understanding Cervical Ectropion

Cervical ectropion is a condition that occurs when the columnar epithelium of the cervical canal extends onto the ectocervix, where the stratified squamous epithelium is located. This happens due to elevated levels of estrogen, which can occur during the ovulatory phase, pregnancy, or with the use of combined oral contraceptive pills. The term cervical erosion is no longer commonly used to describe this condition.

Cervical ectropion can cause symptoms such as vaginal discharge and post-coital bleeding. However, ablative treatments such as cold coagulation are only recommended for those experiencing troublesome symptoms. It is important to understand this condition and its symptoms in order to seek appropriate medical attention if necessary.